Andy Richards CBE
Andy is an entrepreneur and investor with an established track record in founding and scaling up innovative life-science, biotechnology and digital health companies in the UK. He is currently Chairman of Congenica, Abcodia, Closed Loop Medicine, Arecor and Ieso Digital Health and is a Director of Owlstone Medical and Cancer Research Technology (the commercial board of CRUK). He is an advisor to several investment funds including Cambridge Innovation Capital and the UCL Technology Fund, is Chair of the CRUK Seed Fund and is a director of the Scale-Up Institute. He is also a council member of the MRC and continues to have an active interest in the evolution of the Babraham Research Campus.
Andy is a Cambridge Graduate with a PhD in Chemistry and an early career spanning positions with ICI (now AstraZeneca) and PA Technology. He was a founder and executive director of Chiroscience plc until its merger with Celltech in 1999 and since that time he has founded, invested in and helped to scale more than 25 innovative ventures including companies such as Vectura, Arakis, Cambridge Biotechnology Ltd and Geneservice. Andy is also a founder member of the Cambridge Angels.
Andy is passionate about science and the translation of science to do good for society. The life-sciences and healthcare sectors provide the perfect arena for translating science into technology that can help people around the world. He received a CBE for services to the life-sciences in 2015.
Leonardo Royal Hotel London Tower Bridge16 May 2023